Status
Conditions
Treatments
About
One centre follow-up study on safety and efficacy of treatment with rituximab among patients with RA during 4 year period. Basic data is collected for the national register of biologicals.
Full description
Data is collected on regular visits in the outpatient department. In collection national register forms have been used.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
49 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal